-
Mashup Score: 0FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs - 8 month(s) ago
The FDA has postponed its plans to enforce a law designed to thwart counterfeit or diverted medicines passing through the pharmaceutical supply chain.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Breakthrough in solid-state storage innovates how biological materials are stored and handled - 9 month(s) ago
Scientists have developed a novel method for storing biological materials in the form of a pill or a tablet, which dissolves in water for on-demand use. The innovation could overcome current limitations involving in the storage and handling of products derived from living cells used for a variety of health care and scientific research purposes, including pharmaceuticals and diagnostic testing tools.
Source: www.eurekalert.orgCategories: General Medicine News, Latest HeadlinesTweet-
A research team @CalPoly announce novel method for storing biological materials with potential benefit for handling of #medicines and diagnostic testing #chemicalbiology #pharmaceuticals https://t.co/BdbsI9eVwZ
-
-
Mashup Score: 1
July 14, 2023 — Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases. Versanis’ lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @EliLillyandCo @VersanisBio1 A definitive agreement was reached for Lilly to acquire Versanis, a private clinical-stage #biopharmaceutical company focused on the #development of new #medicines for the treatment of #cardiometabolic #diseases: https://t.co/GFLoVTAG3B
-
-
Mashup Score: 0Thinking Pharma on a Friday: Europe's Big Reforms for a Health Union & the U.S. 50-State Fragments - HealthPopuli.com - 1 year(s) ago
The COVID-19 pandemic re-shaped European Union leaders to reimagine healthcare, public health, and health citizenship in the EU. Welcome to #HealthUnion, the hashtag that the European Commission has adopted with the vision of assuring access to medicines for all people living in the 27-nation EU area — regardless of socioeconomic status. On 26th April 2023, the EC unveiled the most…
Source: HealthPopuli.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Thinking abt new @EU_Commission #pharma policy-#HealthUnion for #medicines vis-a-vis 50-state fragmentation in US https://t.co/C8eTIJdlIu #EUHealth regs look to reshape #pharmaceuticals for all Europeans' #healthequity #healthcitizens #healthaccess #healthequity #womenshealth https://t.co/zOl7EwcYgJ
-
-
Mashup Score: 1
In its latest bid to upend the pharmaceutical supply chain, the Mark Cuban Cost Plus Drug Company has enlisted three dozen pharmacies around the U.S. that will accept a card that consumers can use to purchase prescription medicines at lower prices.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Mark Cuban’s drug company creates a pharmacy network to challenge PBMs.. https://t.co/R94JpkcCBK #pharma #MarkCuban #pharmacies #PBM #medicines
-
-
Mashup Score: 1Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study - 1 year(s) ago
Objectives To complement Sustainable Development Goal (SDG) indicator 3.b.3 that monitors access to medicines for all, a corresponding child-specific methodology was developed tailored to the health needs of children. This methodology could aid countries in monitoring accessibility to paediatric medicines in a validated manner and on a longitudinal basis. We aimed to provide proof of concept of…
Source: BMJ OpenCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Sustainable Development Goal #SDG indicator for measuring availability and affordability of #medicines for #children: a proof-of-concept study https://t.co/Fo5YyGHaC5 https://t.co/0Z8xtYjFan
-
-
Mashup Score: 0
“The European Commission has always been fond of tiered pricing, despite the growing evidence over the last decade and a half that it does not really work,” said Ellen ‘t Hoen, a former head of the Medicines Patent Pool.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
European Union drug pricing proposal for the pandemic treaty generates pushback.. https://t.co/efNJBAqa6u #pharma #WHO #pandemic #diagnostics #vaccines #medicines
-
-
Mashup Score: 2
This is “biology’s century,” @matthewherper writes. But we’re approaching a moment when changes in what we understand are every bit as terrifying as exhilarating.
Source: STATCategories: Hem/Oncs, Latest HeadlinesTweet-
Terrific piece by @matthewherper on rapid advances in #medicines--on becoming "unable to tell what works and what doesn’t, and what is safe and what isn’t." What happens when new biological technologies outpace our ability to assess them? https://t.co/tPEIIR0vdk #clinicaltrials
-
-
Mashup Score: 0The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis - 1 year(s) ago
Drug repurposing is a major field of value-added medicine. It involves investigating and evaluating existing drugs for new therapeutic purposes that address unmet healthcare needs. Several unmet needs in allergic rhinitis could be improved by drug repurposing. This could be game-changing for disease management. Current medications for allergic rhinitis are centered on continuous long-term…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! The #Allergic #Rhinitis and Its #Impact on #Asthma ( #ARIA) Approach of #Value- #Added #Medicines: As-Needed #Treatment in #Allergic #Rhinitis https://t.co/Pt0e8EKljS https://t.co/sfOTRmxgwL
-
-
Mashup Score: 0The Patient as Payer: Implications on Healthcare Consumers - 2 year(s) ago
This playbook explains the implications of the growing financial management role for patients.
Source: resources.industrydive.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Patients morphing into #healthconsumers...now, payers #Healthcare costs crowding out other household spending....what does this mean for #pharma & #medicines? https://t.co/OXAjVgYnqG My collaboration w @GoodRx playbook offers calls-to-action for #Rx #medicines & #retailhealth https://t.co/TSxDkLSDW2
-
FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs.. https://t.co/8UKutHXlTM #pharma #FDA #counterfeit #medicines #supplychain $GILD $JNJ